Evidence map›Paper›PMID 40576494›Full record

ArticleChemistryOpen2025

Facile and Practical Synthesis of Substituted Piperidine-2,6-Diones Under Transition-Metal Free Condition.

Yue-Hua Liu, Zhang-Qin Xue, Kai-Wen Yang, Hao-Wen Yin, Bo Yang, Rui Zhang, Hao Zhong, Zhu-Shuang Bai

Abstract read
In one paragraph

Article in ChemistryOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yue-Hua LiuSchool of Pharmaceutical Sciences and Institute of Materia Medical, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission (Shandong Academy of Medical Sciences), Key Lab for Rare and Uncommon Diseases of Shandong Province, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Zhang-Qin XueSchool of Pharmaceutical Sciences and Institute of Materia Medical, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission (Shandong Academy of Medical Sciences), Key Lab for Rare and Uncommon Diseases of Shandong Province, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Kai-Wen YangSchool of Pharmaceutical Sciences and Institute of Materia Medical, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission (Shandong Academy of Medical Sciences), Key Lab for Rare and Uncommon Diseases of Shandong Province, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Hao-Wen YinSchool of Pharmaceutical Sciences and Institute of Materia Medical, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission (Shandong Academy of Medical Sciences), Key Lab for Rare and Uncommon Diseases of Shandong Province, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Bo YangDepartment School of Chemical Engineering and Food Science, Hubei University of Arts and Science, 296 Longzhong Road, Xiangyang, 441053, Hubei, P. R. China.
Rui ZhangHubei Key Laboratory of Low Dimensional Optoelectronic Material and Devices, Hubei University of Arts and Science, 296 Longzhong Road, Xiangyang, 441053, Hubei, P. R. China.ORCID https://orcid.org/0000-0001-8786-3068
Hao ZhongMedical Science and Technology Innovation Center (Institute of Translational Medicine), Shandong First Medical University and Shandong Academy of Medical Sciences), Jinan, 250117, Shandong, China.
Zhu-Shuang BaiSchool of Pharmaceutical Sciences and Institute of Materia Medical, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission (Shandong Academy of Medical Sciences), Key Lab for Rare and Uncommon Diseases of Shandong Province, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.

Funding

Distinguished Young Scholars of Shandong Province 2022HWYQ-001National Natural Science Foundation of China 21907059National Natural Science Foundation of China 22001147Natural Science Foundation of Hubei Province of China 2022CFB779Natural Science Foundation of Shandong Province ZR2021MB102Taishan Scholars Project of Shandong Province tsqn202103027
6 · The paper itself

Abstract

Substituted piperidine-2,6-diones are privileged scaffolds in numerous bioactive molecules and their facile and practical preparation still remains unsolved. In this paper, a facile and practical approach for the construction of α-substituted and α,α-/α,β-disubstituted piperidine-2,6-diones from abundant methyl acetates and acrylamides under transition-metal free condition was disclosed. It features mild reaction condition, operational simplicity, and excellent functional group tolerance, delivering a wide range of piperidine-2,6-diones in moderate to good yield. Furthermore, the application potential was further demonstrated by reaction scale-up (5 kilo-gram scale) and bio-active molecule synthesis (Aminoglutethimide and Niraparib). Additional control experiments revealed that the radical process could be excluded from this reaction and a michael addition/intramolecular imidation cascade sequence was proposed based on the control experiments. All these results demonstrated its significant application potential both in academic and industrial production.

Indexed as

Basic promoterFacile and practical synthesisMichael addition/intramolecular imidation cascadePiperidine-2,6-dione scaffoldTransition-metal free

Identifiers

PMID40576494
PMCPMC12598798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.